AKT1 and acute lymphoblastic leukemia: Furthermore, we observed that Cyr61 could effectively promote ALL cell survival through the AKT/NF-κB pathway by up-regulating Bcl-2 and that this effect was abrogated using neutralizing antibodies against human Cyr61.